LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 7.01 | 17.25 | 763 | 389 | 1.9589 | 1.3226 | MN20160310_N02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 7.01 | 17.25 | 1 | 389 | 0.0026 | -0.4692 | MN20160310_N02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 7.01 | 17.25 | 781 | 389 | 2.0051 | 1.3346 | MN20160310_N02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 8.98 | 17.25 | 21 | 445 | 0.0472 | 0.0428 | MN20160310_N02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 8.98 | 17.25 | 829 | 445 | 1.8626 | 1.2837 | MN20160310_N02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 8.98 | 17.25 | 1 | 445 | 0.0022 | -0.4552 | MN20160310_N02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 8.98 | 17.25 | 835 | 445 | 1.8761 | 1.2872 | MN20160310_N02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 10.95 | 17.25 | 34 | 471 | 0.0721 | 0.1528 | MN20160310_N02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 10.95 | 17.25 | 871 | 471 | 1.8470 | 1.2744 | MN20160310_N02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 10.95 | 17.25 | 1 | 471 | 0.0021 | -0.4494 | MN20160310_N02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 10.95 | 17.25 | 885 | 471 | 1.8767 | 1.2820 | MN20160310_N02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 12.91 | 17.25 | 61 | 494 | 0.1233 | 0.2980 | MN20160310_N02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 12.91 | 17.25 | 905 | 494 | 1.8288 | 1.2655 | MN20160310_N02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 12.91 | 17.25 | 1 | 494 | 0.0020 | -0.4446 | MN20160310_N02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 12.91 | 17.25 | 926 | 494 | 1.8712 | 1.2763 | MN20160310_N02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 14.88 | 17.25 | 159 | 534 | 0.2975 | 0.5658 | MN20160310_N02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 14.88 | 17.25 | 991 | 534 | 1.8543 | 1.2656 | MN20160310_N02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 14.88 | 17.25 | 1 | 534 | 0.0019 | -0.4373 | MN20160310_N02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 14.88 | 17.25 | 1012 | 534 | 1.8936 | 1.2752 | MN20160310_N02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 16.85 | 17.25 | 345 | 655 | 0.5263 | 0.7697 | MN20160310_N02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 16.85 | 17.25 | 1066 | 655 | 1.6261 | 1.1941 | MN20160310_N02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 16.85 | 17.25 | 47 | 655 | 0.0717 | 0.2104 | MN20160310_N02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 16.85 | 17.25 | 1102 | 655 | 1.6810 | 1.2081 | MN20160310_N02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 18.82 | 17.25 | 635 | 800 | 0.7933 | 0.9181 | MN20160310_N02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 18.82 | 17.25 | 1184 | 800 | 1.4791 | 1.1465 | MN20160310_N02 | E03 |